Radiation oncologist Dr. Daniel Przybysz discusses AI integration, global clinical trial equity, and targeted lung cancer ...

Cureety has acquired Reimagine Care, combining Cureety’s therapy-specific oncology monitoring and clinical intelligence with ...

Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ...

Wilson's purchase increases his total equity stake by 9% following a 62% one-year stock return, signaling confidence in the ...

Low was selected for his outstanding contributions to the field of radiation oncology through research and professional ...

Reimagine Care has been acquired by Cureety. Together, they will build the future of precision oncology care. Together, ...

N-Power Medicine has successfully secured $32 million in a Series B financing round, a significant milestone that will ...

In 'Empowering Community Oncology: Infrastructure Investments for Bringing Novel RRFL Therapies to Patients,' Tara Graff, DO, ...

Sept 1 (Reuters) - Oncology company Novocure said on Tuesday a cybersecurity incident involving unauthorized access to ...

Retail traders are treating Novavax as a cancer-vaccine play today, but the price action shows a single-name bid rather than ...

The rapidly growing company quietly relocated this year.

CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presentations at the Cantor Fitzgerald and Morgan ...